Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | POLQ | O75417 | 1/20 | 0.30 |
| ▸ | ESRRA | P11474 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13382014 | 0.88 | POLQ (0.41) | POLQESRRA | |
| SCHEMBL13398860 | 0.87 | MAPK14 (0.32) | — | |
| SCHEMBL13382013 | 0.84 | NR3C2 (0.36) | FFAR1 | |
| SCHEMBL13382009 | 0.80 | FFAR1 (0.40) | FFAR4FFAR1POLQ | |
| SCHEMBL13398660 | 0.79 | MAOA (0.34) | — | |
| SCHEMBL13382012 | 0.78 | IDO1 (0.39) | FFAR4FFAR1 | |
| SCHEMBL13381962 | 0.77 | TDP1 (0.39) | — | |
| SCHEMBL13382015 | 0.77 | MAPT (0.38) | — | |
| SCHEMBL13382008 | 0.77 | MAOB (0.42) | — | |
| SCHEMBL13381974 | 0.76 | RXRA (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | NR2C2, NR4A3, NR0B2 | FFAR4 570/4885FFAR1 554/4885POLQ 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.